UAMY Q2 2026 Earnings Call Summary

1Key Financial Results and Metrics

Revenue: $7.9 million for Q2 2026, down 25% year-over-year from $10.5 million in Q2 2025. However, this represents a 17% sequential increase from Q1 2026 ($6.8 million).

Year-to-Date Revenue: $14.7 million, a 16% decline from $17.5 million in the first half of 2025.

Antimony Revenue: $5.9 million in Q2 2026, down from $9.6 million in Q2 2025, despite a 26% increase in pounds sold (428,000 pounds).

Average Selling Price: Dropped 52% to $13.70 per pound from $28.32 per pound; average cost per pound decreased by 33% to $13.34.

Gross Profit: $600,000 (7% margin), down from $2.8 million (27% margin) in the prior year.

Operating Loss: $7 million, including $3.4 million in noncash items.

Net Income: Reported at $100,000, down from $200,000 in the prior year.

Cash Position: $41.4 million in cash and cash equivalents, up from $3.2 million at the end of Q1 2026; total liquidity (including U.S. Treasuries) at $62.2 million.

Inventory: Increased to $21.6 million, reflecting a strategic buildup to meet anticipated demand.

2Strategic Updates and Business Highlights

DLA Contract: Progressing under a $245 million contract with the Defense Logistics Agency, with first deliveries of antimony ingots expected to generate significant revenue in Q3 and Q4.

Mining Activities: Active mining resumed at Stibnite Hill, Montana, with additional exploration in Alaska and Ontario. Significant ore has been mined and is being processed.

Zeolite Segment: Revenue increased by 110% year-over-year to $1.9 million, driven by strong sales in cattle nutrition.

Institutional Ownership: Increased to over 57%, up from 42% at the end of Q1, reflecting successful marketing efforts.

3Forward Guidance and Outlook

Revenue Guidance: Revised down to $60-$75 million for the year, primarily due to declining antimony prices.

Production Plans: Anticipate ramping up deliveries under the DLA contract, with expectations of improved financial performance in the latter half of 2026.

4Bad News, Challenges, or Points of Concern

Declining Antimony Prices: Significant drop in market prices impacting revenue and margins.

Operating Losses: Increased operating expenses due to higher salaries, share-based compensation, and professional fees, contributing to a substantial operating loss.

Delayed Revenue Recognition: Issues with government inspections and approvals have delayed revenue from DLA shipments that were expected in Q2.

Market Volatility: Uncertainty regarding future antimony prices, heavily influenced by international dynamics, particularly from China.

5Notable Q&A Insights

Delivery Expectations: Management confirmed that while they aim to fulfill the $57 million DLA order, pricing remains a significant concern.

Government Grants: Discussions regarding potential grants are ongoing, but timelines for updates remain uncertain.

Production in Alaska: Currently, no antimony production is occurring in Alaska; confidence exists for future discoveries.

Strategic Transactions: The company is exploring equity positions in potential government partnerships, indicating a shift from traditional grant funding. Overall, while UAMY shows potential for growth through strategic contracts and increased production, it faces significant challenges from market price fluctuations and operational losses.